RheumNow
Avatar

Tocilizumab Approved by the FDA for SSc-induced ILD: Does It Improve the Rate of Lung Function & What Are the Dosing Recommendations? What Is the Association Between Gout and Weight?

By RheumNow FEATURING John J. Cush
By RheumNow FEATURING John J. Cush
582 views
March 15, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

28:46
Boehringer Ingelheim

Systemic Sclerosis-Associated Interstitial Lung Disease: A Patient&#…

Feat. E. Volkmann

Featured Video

39:42
Boehringer Ingelheim

Barriers in Diagnosing Fibrosing Interstitial Lung Diseases (ILDs)

Feat. M. Zlupko

Related Content

AUTOPLAY
51:53
Shaheen Islam

ATS 2022: Approach to Lung Nodules in 2022

16:13
3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

Post COVID-19 Lung Complications

Feat. M. Padilla
53:31
CHEST 2022 Coverage

Approaching Sarcoidosis Therapy From a 21st Century Perspective

Feat. D. Culver
19:21
CHEST 2022 Coverage

A Radiologist's Approach to Subsolid Pulmonary Nodules

Feat. A. Guttentag
07:57
Temple Lung Center

Clinical Trials for Pulmonary Fibrotic Diseases

Feat. G. Criner
28:18
UCLA Health

Advances and Updates in Sarcoidosis: Diagnosis and Treatment of Pulm…

Feat. J. Belperio
14:00
Temple Lung Center

What Is ILD: Understanding Your Diagnosis

Feat. R. Criner
24:02
CHEST 2022 Coverage

Bronchoscopic Imaging for Interstitial Lung Disease

Feat. G. Zhi Cheng
52:53
University of Colorado Department of Medicine

Interstitial Lung Disease in Rheumatic Diseases

Feat. M. Griffith
25:48
University of Colorado Department of Medicine

Sarcoidosis: Diagnosis and Management

Feat. N. Held
14:58
Temple Lung Center

The Role of Pulmonary Rehabilitation in ILD

Feat. S. Pourshadid
21:34
CHEST 2022 Coverage

Management and Treatment Decisions in Progressive Pulmonary Fibrosis

Feat. T. Kulkarni
34:08
Keck School of Medicine of USC

Medical Marijuana in Rheumatology: Fact or Fiction?

Feat. A. Wells
09:19
Toby Maher

Rituximab versus Cyclophosphamide for the Treatment of Connective Ti…

12:52
The France Foundation

Identifying the Signs and Symptoms of Progressive Pulmonary Fibrosis

Feat. V. Khangoora
16:54
3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

Lymphangioleiomyomatosis: A Clinical Overview

Feat. F. Mccormack
25:25
Keck School of Medicine of USC

Update on the New ANA Classification System

Feat. E. Taylor-Albert
43:45
University of Colorado Department of Medicine

Advances in Rheumatoid Arthritis Associated Interstitial Lung Disease

Feat. J. Lee
31:36
Keck School of Medicine of USC

Pulmonary Manifestations of SLE: An Update

Feat. F. Quismorio
17:49
NYU Langone

Antifibrotic Therapy for Stage 4 Pulmonary Sarcoidosis

Feat. M. A Judson